Cargando…

Review targeted drug delivery systems for norcantharidin in cancer therapy

Norcantharidin (NCTD) is a demethylated derivative of cantharidin (CTD), the main anticancer active ingredient isolated from traditional Chinese medicine Mylabris. NCTD has been approved by the State Food and Drug Administration for the treatment of various solid tumors, especially liver cancer. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Bing-Tao, Sun, Jing, Shi, Ya-Jun, Zhang, Xiao-Fei, Zou, Jun-Bo, Cheng, Jiang-Xue, Fan, Yu, Guo, Dong-Yan, Tian, Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719664/ https://www.ncbi.nlm.nih.gov/pubmed/36463199 http://dx.doi.org/10.1186/s12951-022-01703-3

Ejemplares similares

Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
por: Huang, Mian, et al.
Publicado: (2023)

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
por: Zhai, Bing-Tao, et al.
Publicado: (2022)

Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption
por: Bei, Yong-yan, et al.
Publicado: (2012)

Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate
por: Zhu, Jing, et al.
Publicado: (2018)

Norcantharidin Induces HL-60 Cells Apoptosis In Vitro
por: Jiang, You-Ming, et al.
Publicado: (2012)

Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013)

Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities
por: Pan, Mu-Su, et al.
Publicado: (2020)

Correction: Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013)

Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin
por: Liu, Qian, et al.
Publicado: (2022)

Exploring the Scientific Rationality of the Phenomenon of “Different Dosage Forms of the Same Prescription” of Chinese Proprietary Medicine Based on Biopharmaceutical Properties of Powder and Pill of Chuanxiong Chatiao Prescription
por: Qu, Zhong-huan, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Norcantharidin Derivatives Possessing an Aromatic Amine Moiety as Antifungal Agents
por: Wang, Yang, et al.
Publicado: (2015)

Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers
por: Guan, Min, et al.
Publicado: (2012)

Non-target effects on soil microbial parameters of the synthetic pesticide carbendazim with the biopesticides cantharidin and norcantharidin
por: Shao, Hainan, et al.
Publicado: (2017)

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway
por: Wang, Yingcong, et al.
Publicado: (2023)

Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells
por: Zhang, Xiumei, et al.
Publicado: (2019)

Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin
por: Ma, Qixiang, et al.
Publicado: (2018)

Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway
por: Zheng, Jie, et al.
Publicado: (2014)

Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells
por: Du, Li-jun, et al.
Publicado: (2021)

Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells
por: Ye, Kun, et al.
Publicado: (2017)

Facile Chemical Access to Biologically Active Norcantharidin Derivatives from Biomass
por: Galkin, Konstantin I., et al.
Publicado: (2017)

FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells
por: Zhang, Qiao-Yan, et al.
Publicado: (2017)

Pickering emulsion technology based on the concept of “the combination of medicine and adjuvant” to enhance the oxidation stability of volatile oils in solid preparations—taking Lingzhu Pulvis as an example
por: Peng, Lei, et al.
Publicado: (2022)

Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma
por: Gao, Benjian, et al.
Publicado: (2021)

Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS
por: Ding, Xin-Yuan, et al.
Publicado: (2012)

Strontium/Chitosan/Hydroxyapatite/Norcantharidin Composite That Inhibits Osteosarcoma and Promotes Osteogenesis In Vitro
por: Huang, Zhipeng, et al.
Publicado: (2020)

Norcantharidin down-regulates iron contents in the liver and spleen of lipopolysaccharide-treated mice
por: Zheng, Jie, et al.
Publicado: (2022)

Norcantharidin Induced DU145 Cell Apoptosis through ROS-Mediated Mitochondrial Dysfunction and Energy Depletion
por: Shen, Bo, et al.
Publicado: (2013)

Norcantharidin inhibits the DDR of bladder cancer stem-like cells through cdc6 degradation
por: Shi, Xianghua, et al.
Publicado: (2019)

Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma
por: Liu, Minchen, et al.
Publicado: (2020)

Norcantharidin Facilitates LPS-Mediated Immune Responses by Up-Regulation of AKT/NF-κB Signaling in Macrophages
por: Zhao, Qufei, et al.
Publicado: (2012)

Author Correction: FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells
por: Zhang, Qiao-Yan, et al.
Publicado: (2017)

Multifunctional nanocarriers for targeted drug delivery and diagnostic applications of lymph nodes metastasis: a review of recent trends and future perspectives
por: Lan, Huan-Rong, et al.
Publicado: (2023)

Knockdown of interferon-stimulated gene 15 affects the sensitivity of hepatocellular carcinoma cells to norcantharidin
por: Chen, Baoxiang, et al.
Publicado: (2019)

Evaluation of the Clinical Efficacy of the Classic Prescription “Baihe Dihuang Decoction” Based on Meta-Analysis
por: Peng, Lei, et al.
Publicado: (2022)

Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling
por: Sun, Chao-Yue, et al.
Publicado: (2017)

A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma
por: Xie, Ming-Hua, et al.
Publicado: (2022)

Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer
por: Li, Xiu-Yan, et al.
Publicado: (2021)

Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway
por: Wang, Lei, et al.
Publicado: (2022)

Norcantharidin enhances antitumor immunity of GM‐CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells
por: Mo, Lijun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r6badqneupf70a74erssmiaatl